Metastatic HER2-positive carcinoma of breast

Metastatic HER2-positive carcinoma of the breast is an advanced, stage IV malignancy arising from the epithelial tissue of the mammary gland that has disseminated beyond the breast and regional lymph nodes to distant anatomical sites, such as the bones, liver, lungs, or brain

Metastatic HER2-positive carcinoma of the breast is an advanced, stage IV malignancy arising from the epithelial tissue of the mammary gland that has disseminated beyond the breast and regional lymph nodes to distant anatomical sites, such as the bones, liver, lungs, or brain This molecular alteration drives constitutively active intracellular signaling pathways that promote accelerated cellular proliferation, invasive potential, and historically aggressive tumor biology Clinically, confirmation...

Pathophysiologically, this disease subtype is defined by the amplification of the *ERBB2* gene and consequent overexpression of the human epidermal growth factor receptor 2 (HER2) tyrosine kinase protein This molecular alteration drives constitutively active intracellular signaling pathways that promote accelerated cellular proliferation, invasive potential, and historically aggressive tumor biology

Pathophysiologically, this disease subtype is defined by the amplification of the *ERBB2* gene and consequent overexpression of the human epidermal growth factor receptor 2 (HER2) tyrosine kinase protein Clinically, confirmation via immunohistochemistry or in situ hybridization is essential, as this distinct biomarker profile renders the disseminated carcinoma amenable to HER2-directed therapies